WWM
PFE icon

Windsor Wealth Management’s Pfizer PFE Stock Holding History

Windsor Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$217K Buy
6,542
+410
+7% +$14.5K 0.04% 148
2023
Q2 		$225K Buy
6,132
+364
+6% +$14.2K 0.04% 152
2023
Q1 		$241K Buy
5,768
+6
+0.1% +$259 0.05% 142
2022
Q4 		$293K Buy
5,762
+51
+0.9% +$2.44K 0.06% 125
2022
Q3 		$242K Buy
5,711
+2
+0% +$97 0.06% 130
2022
Q2 		$301K Sell
5,709
-21,148
-79% -$1.08M 0.08% 121
2022
Q1 		$1.48M Sell
26,857
-1,410
-5% -$73.2K 0.27% 68
2021
Q4 		$1.54M Sell
28,267
-3,658
-11% -$181K 0.28% 71
2021
Q3 		$1.37M Buy
31,925
+10,966
+52% +$486K 0.29% 71
2021
Q2 		$821K Sell
20,959
-5,487
-21% -$213K 0.18% 111
2021
Q1 		$958K Buy
26,446
+3,549
+15% +$126K 0.23% 91
2020
Q4 		$843K Buy
22,897
+565
+3% +$20.7K 0.21% 95
2020
Q3 		$803K Buy
22,332
+3,069
+16% +$108K 0.23% 92
2020
Q2 		$598K Buy
19,263
+160
+0.8% +$5.44K 0.19% 108
2020
Q1 		$592K Sell
19,103
-11,970
-39% -$408K 0.24% 94
2019
Q4 		$1.16M Buy
31,073
+6,767
+28% +$241K 0.43% 58
2019
Q3 		$800K Sell
24,306
-4,192
-15% -$152K 0.35% 77
2019
Q2 		$1.18M Buy
28,498
+9,548
+50% +$379K 0.52% 51
2019
Q1 		$764K Buy
18,950
+677
+4% +$27.1K 0.43% 70
2018
Q4 		$757K Sell
18,273
-8,476
-32% -$352K 0.52% 54
2018
Q3 		$1.12M Buy
26,749
+8,446
+46% +$325K 0.73% 33
2018
Q2 		$630K Buy
18,303
+442
+2% +$15.1K 0.49% 55
2018
Q1 		$601K Sell
17,861
-146
-0.8% -$5.02K 0.51% 51
2017
Q4 		$619K Buy
+18,007
New +$614K 0.53% 46

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Windsor Wealth Management's PFE Position: Q3 2023 in Review

Windsor Wealth Management increased its Pfizer (PFE) stake by 6.7% in Q3 2023, buying an estimated $14.5K and bringing the position to 6,542 shares worth $217K. The position accounts for 0.04% of the portfolio, ranked #148.

Windsor Wealth Management first reported a position in PFE in Q4 2017 and has held it in 24 quarters since. The position peaked at $1.54M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Windsor Wealth Management held 6,542 shares of Pfizer worth $217K as of Q3 2023.
  • Windsor Wealth Management bought 410 Pfizer shares in Q3 2023, an estimated $14.5K.
  • Pfizer made up 0.04% of Windsor Wealth Management's portfolio in Q3 2023, its #148 holding.
  • Windsor Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 24 quarters since.
  • Windsor Wealth Management's Pfizer position peaked at $1.54M in Q4 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Windsor Wealth Management's 13F filing for Q3 2023, filed 24 Oct 2023.